ARCHIVES

Conversation with The Cancer Letter: UT System Vice Chancellor Shine Describes Rationale for Granting Waiver to DePinho

This article is from The Cancer Letter archive.

Vol. 38 No. 40 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

NIH Reconsiders Closing A Meeting Of Advisory Group

January 13, 1995

Virus Program Changes reviews Subcommittee Report Set Fro June

November 23, 1974

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

May 31, 2013

Rabson Recommended For NCI Acting Director, Will be Top Prospect For Permanent Appointment

August 26, 1988

US Oncology To Participate In Firm’s Ovarian Cancer Trial.

January 26, 2001

ACS President Calls On Physicians To Take Advantage Of “Untapped Opportunities” In Cancer Prevention

March 27, 1987